Construction of recombinant oncolytic vaccinia virus rVV-CCL5-SSTR2-Luc+ carrying both CCL5 and SSTR2 genes in vitro and preliminary verification of its antitumor activity
机构:[1]Kunming University of Science and Technology, Kunming, China, the People's Republic,[2]The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China, the People's Republic云南省第一人民医院
第一作者机构:[1]Kunming University of Science and Technology, Kunming, China, the People's Republic,[2]The First People's Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China, the People's Republic
通讯作者:
推荐引用方式(GB/T 7714):
Li D-Y,Fang J. -J,Tang H..Construction of recombinant oncolytic vaccinia virus rVV-CCL5-SSTR2-Luc+ carrying both CCL5 and SSTR2 genes in vitro and preliminary verification of its antitumor activity[J].EUROPEAN JOURNAL OF IMMUNOLOGY.2019,49:1655-1656.
APA:
Li, D-Y,Fang, J. -J&Tang, H..(2019).Construction of recombinant oncolytic vaccinia virus rVV-CCL5-SSTR2-Luc+ carrying both CCL5 and SSTR2 genes in vitro and preliminary verification of its antitumor activity.EUROPEAN JOURNAL OF IMMUNOLOGY,49,
MLA:
Li, D-Y,et al."Construction of recombinant oncolytic vaccinia virus rVV-CCL5-SSTR2-Luc+ carrying both CCL5 and SSTR2 genes in vitro and preliminary verification of its antitumor activity".EUROPEAN JOURNAL OF IMMUNOLOGY 49.(2019):1655-1656